Single Dose Pharmacokinetics of Oral Dextran Sulfate (UA001) and Intravenous Dextran Sulfate in Healthy Volunteers
Status:
Completed
Trial end date:
1989-10-01
Target enrollment:
Participant gender:
Summary
To evaluate how the drug dextran sulfate (DS) is absorbed by the stomach and intestines when
taken by mouth. To evaluate its effect on blood coagulation.
DS has been reported to have anti-HIV activity. However, it is not known how much of the drug
is absorbed into the bloodstream and can be used by the body when DS is taken by mouth.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)